Article (Scientific journals)
Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy.
Gennigens, Christine; DE CUYPERE, Marjolein; SEIDEL, Laurence et al.
2020In Cancer Medicine, p. 1-12
Peer Reviewed verified by ORBi
 

Files


Full Text
Correlation between hematological parameters and outcome in patients.... article CG.pdf
Publisher postprint (395.06 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
chemoradiotherapy; hemoglobin; locally advanced cervical cancer; neutrophil; transfusion; white blood cell; oncology
Abstract :
[en] BACKGROUND: Hemoglobin (Hb), white blood cell (WBC), and polymorphonuclear neutrophil (PMN) blood counts may be correlated with outcomes in patients with locally advanced cervical cancer. METHODS: Hb, WBC, and PMN counts were measured at diagnosis and during concomitant cisplatin-based chemoradiotherapy (CCRT) in a retrospective sample of 103 patients between 2010 and 2017. Red blood cell (RBC) transfusions were also recorded. The associations between hematological variables and patient overall survival (OS) and recurrence-free survival (RFS) were assessed by Cox regression models. RESULTS: The 3-year OS and RFS rates were 81.4% and 76.8%, respectively. In addition to tumor size and smoking, OS and RFS were found to be significantly associated with changes in WBC and PMN counts from the first to the last cisplatin cycle. Hb count throughout the treatment and RBC transfusions were not predictive of outcome. CONCLUSIONS: This study found no association between Hb count or RBC transfusions and outcome. The daily practice of maintaining the Hb count above 12 g/dL during CCRT should be weighed against the potential risks of transfusions. Drops in WBC and PMN counts during treatment positively impacted OS and RFS and could, therefore, serve as biomarkers during CCRT to adapt the follow-up and consider the need for adjuvant systemic treatments.
Disciplines :
Oncology
Author, co-author :
Gennigens, Christine  ;  Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
DE CUYPERE, Marjolein ;  Centre Hospitalier Universitaire de Liège - CHU > Département de gynécologie-obstétrique > Secteur oncologie
SEIDEL, Laurence  ;  SEIDEL, Laurence mailto [Centre Hospitalier Universitaire de Liège - CHU > Département de gestion des systèmes d'informations (GSI) > Secteur d'appui à la recherche clinique et biostatistique
HERMESSE, Johanne ;  Centre Hospitalier Universitaire de Liège - CHU > Département de Physique Médicale > Service médical de radiothérapie
Barbeaux, Annelore
Forget, Frédéric
Albert, Adelin  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Département des sciences de la santé publique
Jerusalem, Guy  ;  Université de Liège - ULiège > Département des sciences cliniques > Oncologie
Kridelka, Frédéric ;  Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique
Language :
English
Title :
Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy.
Publication date :
2020
Journal title :
Cancer Medicine
eISSN :
2045-7634
Publisher :
Wiley, Oxford, United Kingdom
Pages :
1-12
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Available on ORBi :
since 13 November 2020

Statistics


Number of views
82 (10 by ULiège)
Number of downloads
5 (5 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
2
OpenCitations
 
3

Bibliography


Similar publications



Contact ORBi